免疫功坊股份有限公司 IMMUNWORK
  • ( EN )
    • EN
    • 繁中
    CLOSE
  • About Us
    • Back
    • Overview
    • Founder
    • Executives
    • Board of directors
  • Technologies
    • Back
    • Overview
    • T-ETMPharmaceuticals
    • Multi-arm linkers
    • Packed multi-arm linkers
    • Cytotoxic drug bundles
    • Chelator bundles
    • Fatty acid bundles
    • Antibody drug conjugates
    • Antibody radionuclide conjugates
  • Products
    • Back
    • Overview
    • TE-1146
    • TE-1132
    • TE-8105
    • TE-8035
    • TE-8214
    • TE-6168
  • News&Honors
  • Contact Us
  • ( English )
    • Back
    • English
    • 繁體中文
  • Copyright © 2017 MIRACLE

News&Honors

Immunwork to present at the 2nd Next-Generation Conjugates Summit in Boston
2023/02
18
Immunwork to present at Biotech Showcase™ 2023 – updates in proprietary ADC / ARC technology platforms and fundraising plan
2023/01
05
【Reported by Economic Daily】Immunwork's novel drugs challenge incurable diseases
2023/01
01
Invited to join the conference – AAMA (Pearl River Delta) 10th Anniversary
2022/11
20
Invited lectures on November 15th, 2022 Antibody Therapeutic Conference - Extended Application of Antibody
2022/11
15
  • 1
  • 2
  • 3
  • 4

Immunwork, Inc., a wholly owned subsidiary of T-E Pharma Holding, a Cayman Island company.

Address: Room C520, Building C, No. 99, Lane 130, Sec. 1, Academia Rd,, Nangang District, Taipei City, Taiwan R.O.C. 115202
Email: bd@immunwork.com or service@immunwork.com
Phone: +886-2-2651-2268
Design assisted by WebTech Webpage design
go top